Volume 10 Issue 6
Nov.  2019
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2019  >  10(6): 702-707
He Li, Li Guangming, Lin Dongdong, et al. Safety application of organs from infectious donors[J]. ORGAN TRANSPLANTATION, 2019, 10(6): 702-707. doi: 10.3969/j.issn.1674-7445.2019.06.012
Citation: He Li, Li Guangming, Lin Dongdong, et al. Safety application of organs from infectious donors[J]. ORGAN TRANSPLANTATION, 2019, 10(6): 702-707. doi: 10.3969/j.issn.1674-7445.2019.06.012
shu

Safety application of organs from infectious donors

doi: 10.3969/j.issn.1674-7445.2019.06.012

  • Liver Transplantation Center, Beijing You'an Hospital Affiliated to Capital Medical University, Beijing 100069, China

More Information
  • Corresponding author: Li Guangming,Email：liguangming917@163.com
  • Received Date: 2019-09-03
    Available Online: 2021-01-19
  • Publish Date: 2019-11-15
    Abstract
  •   Objective  To explore the safety application of organs from infectious donors.  Methods  Clinical data of 67 donors and recipients undergoing orthotopic liver transplantation were retrospectively analyzed. According to the occurrence of infections and infection sites in donors, all recipients were divided into the bloodstream infection group (n=16, donors with non-drug resistant bacterial infections), non-bloodstream infection group (n=20, donors with other site infections) and non-infection group (n=31). Perioperative clinical parameters including preoperative model for end-stage liver disease (MELD) score, operative time, anhepatic phase, intraoperative blood loss and intraoperative blood transfusion were statistically compared among three groups. The recovery of liver function and coagulation function in the recipients was observed at postoperative 1, 3, 7, 14 and 21 d. The incidence rate of complications and mortality rate in the recipients were recorded within 1 month after liver transplantation. The recovery of postoperative infection-related parameters including white blood cell (WBC), neutrophil pet (NE%) and procalcitonin (PCT) level in the recipients was observed. The application rate and application time of restricted antibiotics were recorded.  Results  Perioperative clinical parameters in the recipients did not significantly differ among three groups (all P > 0.05). At each time point after liver transplantation, the liver function, coagulation function, incidence rate of complications and mortality rate in the recipients did not significantly differ among three groups (all P > 0.05). The NE% of recipients at postoperative 3 and 7 d in the bloodstream infection group was significantly higher than those in non-bloodstream infection and non-infection groups (all P < 0.05). The PCT levels of recipients at postoperative 3, 7 and 14 d in the bloodstream infection group were significantly higher than those in the non-bloodstream infection and non-infection groups (all P < 0.05). The application rate and application time of restricted antibiotics in the recipients with bloodstream infections were significantly higher or longer than their counterparts in the non-bloodstream infection and non-infection groups (all P < 0.05).  Conclusions   It is safe to apply liver grafts from donors with bloodstream infection of non-drug resistant bacteria or other site infections when antibiotics are applied as early as possible.

     

    • FullText(HTML)
  • loading
    • References(25)
  • [1]
    WOLACH B, SAZBON L, GAVRIELI R, et al. Early immunological defects in comatose patients after acute brain injury[J]. J Neurosurg, 2001, 94(5):706-711. doi: 10.3171/jns.2001.94.5.0706
    [2]
    MOHAREM HA, FETOUH FA, DARWISH HM, et al. Effects of bacterial translocation on hemodynamic and coagulation parameters during living-donor liver transplant[J]. BMC Anesthesiol, 2018, 18(1):46. DOI: 10.1186/s12871-018-0507-7.
    [3]
    CHONG PP, RAZONABLE RR. Diagnostic and management strategies for donor-derived infections[J]. Infect Dis Clin North Am, 2013, 27(2):253-270. DOI: 10.1016/j.idc.2013.02.001.
    [4]
    LEWIS JD, SIFRI CD. Multidrug-resistant bacterial donor-derived infections in solid organ transplantation[J]. Curr Infect Dis Rep, 2016, 18(6):18. DOI: 10.1007/s11908-016-0526-9.
    [5]
    HU FP, GUO Y, ZHU DM, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014[J]. Clin Microbiol Infect, 2016, 22(Suppl 1): S9-S14. DOI: 10.1016/j.cmi.2016.01.001.
    [6]
    VAN DUIN D, VAN DELDEN C, AST Infectious Diseases Community of Practice. Multidrug-resistant gram-negative bacteria infections in solid organ transplantation[J]. Am J Transplant, 2013, 13 (Suppl 4): 31-41. DOI: 10.1111/ajt.12096.
    [7]
    GOLDBERG E, BISHARA J, LEV S, et al. Organ transplantation from a donor colonized with a multidrug-resistant organism: a case report[J]. Transpl Infect Dis, 2012, 14(3):296-299. DOI: 10.1111/j.1399-3062. 2011.00697.x.
    [8]
    SIMKINS J, MUGGIA V. Favorable outcome in a renal transplant recipient with donor-derived infection due to multidrug-resistant pseudomonas aeruginosa[J]. Transpl Infect Dis, 2012, 14(3):292-295. DOI: 10.1111/j.1399-3062.2011.00674.x.
    [9]
    SINGH N, HUPRIKAR S, BURDETTE SD, et al. Donor-derived fungal infections in organ transplant recipients: guidelines of the American Society of Transplantation, infectious diseases community of practice[J]. Am J Transplant, 2012, 12(9):2414-2428. DOI: 10.1111/j.1600-6143.2012.04100.x.
    [10]
    丁利民, 徐志丹, 李新长, 等.公民逝世后器官捐献供肝保护及功能评估临床分析[J].器官移植, 2017, 8(6):430-434. DOI: 10.3969/j.issn.1674-7445.2017.06.004.

    DING LM, XU ZD, LI XC, et al. Clinical analysis on donor liver protection and function evaluation for organ donation after citizen' s death[J]. Organ Transplant, 2017, 8(6):430-434. DOI:10.3969/j.issn. 1674-7445.2017.06.004.
    [11]
    NELLORE A, FISHMAN JA. Donor-derived infections and infectious risk in xenotransplantation and allotransplantation[J]. Xenotransplantation, 2018, 25(4):e12423. DOI: 10.1111/xen.12423.
    [12]
    BENAMU E, WOLFE CR, MONTOYA JG. Donor-derived infections in solid organ transplant patients: toward a holistic approach[J]. Curr Opin Infect Dis, 2017, 30(4):329-339. DOI: 10.1097/QCO.0000000000000377.
    [13]
    FISCHER SA. Is this organ donor safe?: donor-derived infections in solid organ transplantation[J]. Infect Dis Clin North Am, 2018, 32(3):495-506. DOI: 10.1016/j.idc.2018.04.001.
    [14]
    王婷婷, 孔心涓, 饶伟.边缘性供肝移植术后早期肝功能不全影响因素的研究进展[J/CD].实用器官移植电子杂志, 2016, 4(5): 302-305. DOI: 10.3969/j.issn.2095-5332.2016.05.010.

    WANG TT, KONG XJ, RAO W, et al. Research progress on factors affecting early liver dysfunction after marginal donor liver transplantation[J/CD]. Pract J Organ Transplant (Electr Vers), 2016, 4(5): 302-305. DOI: 10.3969/j.issn.2095-5332.2016.05.010.
    [15]
    PITOUT JD, NORDMANN P, POIREL L. Carbapenemase- producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance[J]. Antimicrob Agents Chemother, 2015, 59(10):5873-5884. DOI:10.1128/AAC. 01019-15.
    [16]
    中华医学会器官移植学分会, 中华预防医学会医院感染控制学分会, 复旦大学华山医院抗生素研究所.中国实体器官移植供者来源感染防控专家共识(2018版)[J].中华器官移植杂志, 2018, 39(1):41-52. DOI: 10.3760/cma.j.issn.0254-1785.2018.01.008.

    Branch of Organ Transplantation of Chinese Medical Association, Branch of Nosocomial Infection Control of Chinese Preventive Medical Association, Antibiotic Research Institute of Fushan University Huashan Hospital. Expert consensus on prevention and control of Chinese solid organ transplant donor source infection (2018 edition)[J]. Chin J Organ Transplant, 2018, 39(1):41-52. DOI: 10.3760/cma.j.issn.0254-1785.2018.01.008.
    [17]
    AIRES-DE-SOUSA M, ORTIZ DE LA ROSA JM, GONÇALVES ML, et al. Epidemiology of carbapenemase-producing Klebsiella pneumoniae in a hospital, Portugal[J]. Emerg Infect Dis, 2019, 25(9):1632-1638. DOI: 10.3201/eid2509.190656.
    [18]
    CAMPOS AC, ALBIERO J, ECKER AB, et al. Outbreak of klebsiella pneumoniae carbapenemase-producing K pneumoniae: a systematic review[J]. Am J Infect Control, 2016, 44(11):1374-1380. DOI: 10.1016/j.ajic. 2016.03.022.
    [19]
    COHEN J, MICHOWIZ R, ASHKENAZI T, et al. Successful organ transplantation from donors with acinetobacter baumannii septic shock[J]. Transplantation, 2006, 81(6):853-855. doi: 10.1097/01.tp.0000203804.95180.6e
    [20]
    ISON MG, GROSSI P, AST Infectious Diseases Community of Practice. Donor-derived infections in solid organ transplantation[J]. Am J Transplant, 2013, 13 (Suppl 4):22-30. DOI: 10.1111/ajt.12095.
    [21]
    WAN Q, LIU H, YE S, et al. Confirmed transmission of bacterial or fungal infection to kidney transplant recipients from donated after cardiac death (DCD) donors in China: a single-center analysis[J]. Med Sci Monit, 2017, 23:3770-3779. doi: 10.12659/MSM.901884
    [22]
    陈小松, 韩龙志, 钱永兵, 等.供体来源碳青霉烯酶类耐药肺炎克雷伯杆菌感染--肝肾移植的差异[J/CD].实用器官移植电子杂志, 2018, 6(1): 45-48. DOI: 10.3969/j.issn.2095-5332.2018.01.011.

    CHEN XS, HAN LZ, QIAN YB, et al. The difference between liver and kidney transplantation--donor derived infection of carbapenemresistant Klebsiella pneumonia[J/CD]. Pract J Organ Transplant (Electr Vers), 2018, 6(1): 45-48. DOI: 10.3969/j.issn.2095-5332.2018.01.011.
    [23]
    KARAISKOS I, ANTONIADOU A, GIAMARELLOU H. Combination therapy for extensively-drug resistant gram-negative bacteria[J]. Expert Rev Anti Infect Ther, 2017, 15(12):1123-1140. DOI:10.1080/14787210.2017. 1410434.
    [24]
    GARBER K. A β-lactamase inhibitor revival provides new hope for old antibiotics[J]. Nat Rev Drug Discov, 2015, 14(7):445-447. DOI: 10.1038/nrd4666.
    [25]
    TUMBARELLO M, TRECARICHI EM, CORONA A, et al. Efficacy of ceftazidime-avibactam salvage therapy in patients with infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae[J]. Clin Infect Dis, 2019, 68(3):355-364. DOI: 10.1093/cid/ciy492.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (148) PDF downloads(12) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return